en

PRODUCT DETAIL

Enhertu 100 mg prášok na koncentrát na infúzny roztok

Code 6497D
MA number EU/1/20/1508/001
Product Form: plc ifc 1x100 mg (liek.inj.skl.jantár.)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
L01FD04 Trastuzumab deruxtecan
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 18.01.2021
Validity: 20.01.2025
SmPC + PL: European Medicines Agency's database
Dokument: Enhertu_Prirucka pre zdravotnickych pracovnikov k prevencii chyb v liecbe.pdf  
Dokument: Enhertu_Prirucka pre zdravotnickych pracovnikov.pdf  
Dokument: Enhertu_Karta pacienta.pdf  
Safety feature Yes
Data update: 03.11.2023
eu-flag.png sk-flag.png